Why it is so challenging to perform economic evaluations of interventions in autism and what to do about it.
Economic studies must capture autism heterogeneity, use cost-sensitive outcomes, and rely on validated tools to move payer budgets.
01Research in Context
What this study did
Tsiplova et al. (2023) looked at why it is so hard to run cost studies for autism services.
They read the literature and listed the main roadblocks.
They also gave tips for fixing each problem.
What they found
The team found three big hurdles.
First, every child with autism is different, so one price tag does not fit all.
Second, most studies pick outcomes payers do not care about.
Third, many tools used to track progress have not been checked for cost value.
How this fits with other research
Gitimoghaddam et al. (2022) show that ABA reviews rarely track quality of life or cost.
Kate et al. pick up that gap and tell us exactly which cost-sensitive outcomes to add.
Wallace-Watkin et al. (2023) list access barriers for poor families.
Kate et al. echo this by urging analysts to include travel, wait-list, and stigma costs in their models.
Kupis et al. (2021) reveal that only 5 % of federal autism money goes to services research.
Kate et al. explain why that shortage hurts payers who need dollar figures before they will fund new programs.
Why it matters
You can start tomorrow. Pick one socially valid target like parent stress or job hours. Track it side-by-side with minutes of therapy. Note the cost of each hour, mile driven, or missed workday. Share these numbers in your next report to the funder. This small step turns your outcome data into the economic story payers want to hear.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add one cost line item, like parent travel minutes, to your next data sheet.
02At a glance
03Original abstract
Economic evaluation is used to determine the optimal provision of services and programs under budget constraints and to inform public and private payer funding decisions. To maximize value-for-money in the design and delivery of programs and services for persons with autism spectrum disorder (ASD), it's essential to generate high-quality economic evidence to inform budget allocation. There is a paucity however, of economic evaluations of interventions for ASD. This is due in part to challenges in conducting economic evaluations in this population and the lack of guidance on suitable approaches. These challenges are related to the inherent heterogeneity of the autistic population; establishing short- and long-term effectiveness; measurement of costs and the availability of valid instruments for collecting economic data; the appropriateness of outcomes for use in economic evaluation; and achieving statistical power. This commentary addresses a lack of awareness and needed guidance on these issues by discussing the challenges and providing recommendations for how economic evaluations in ASD could be improved to generate high-quality evidence for program funding decision-making.
Autism research : official journal of the International Society for Autism Research, 2023 · doi:10.1002/aur.3014